Clinical Trial Update: Evaluation of Gadoterate in Patients With Renal Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating gadoterate meglumine in patients with renal dysfunction was terminated; results were posted on 2025-08-13.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Dysfunction

Drugs mentioned

• Gadoterate meglumine (Gadoterate meglumine)

Snippet

Sponsor: Loyola University | Conditions: Renal Dysfunction | Phase 4 | Status: TERMINATED | Results posted: 2025-08-13